Breaking News Instant updates and real-time market news.

TRVN

Trevena

$0.91

-0.0107 (-1.16%)

04:55
08/13/19
08/13
04:55
08/13/19
04:55

Trevena management to meet with Oppenheimer

Meetings to be held in West Coast on August 12-13 hosted by Oppenheimer.

  • 13

    Aug

TRVN Trevena
$0.91

-0.0107 (-1.16%)

10/12/18
JMPS
10/12/18
NO CHANGE
Target $4
JMPS
Outperform
Trevena price target lowered to $4 from $15 at JMP Securities
JMP Securities analyst Jason Butler said the mixed Advisory Committee vote on Trevena's application for oliceridine is likely to result in an approval delay, but he has not given up on the potential for issues raised by the panel to be addressed with label modifications and post-marketing studies. He now assume the company receiving a CRL as his base case scenario, which would result in an 18-month delay to approval. Butler, who cut his probability of approval for oliceridine to 70% from 90% and lowered his peak sales estimate, reduced his price target on Trevena shares to $4 from $15 but keeps an Outperform rating on the stock.
10/12/18
HCWC
10/12/18
NO CHANGE
Target $3
HCWC
Buy
H.C. Wainwright says FDA nod for Trevena's oliceridine unlikely, but possible
H.C. Wainwright analyst Ed Arce said he does not believe the FDA's approval decision about Trevena's oliceridine is "a foregone conclusion" following yesterday's advisory committee meeting given the mixed vote on approvability. After the vote, at least three panelists who voted "no" said that they struggled with their decision and could have easily voted "yes," according to Arce, who said there is a possibility, "however unlikely," that the FDA could still approve the drug. While he views the November 2 decision as "too hard to call" and keeps a Buy rating on Trevena shares, Arce lowered his price target on the stock to $3 from $7.
11/05/18
HCWC
11/05/18
DOWNGRADE
Target $0.75
HCWC
Neutral
Trevena downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Ed Arce downgraded Trevena to Neutral and lowered his price target for the shares to 75c from $3.00. Following the Complete Response Letter from the FDA on the new drug application for oliceridin, a second-pass PDUFA date is unlikely until early 2020, Arce tells investors in a research note. He believes the CRL "leaves several open questions."
05/31/19
HCWC
05/31/19
INITIATION
Target $3.5
HCWC
Buy
Trevena assumed with a Buy at H.C. Wainwright
H.C. Wainwright analyst Douglas Tsao assumed coverage of Trevena with a Buy rating and $3.50 price target. The analsut believes the questions raised in the Complete Response Letter appear manageable and that Olinvo has a "clear path to approval." He expects Trevena shares to move higher as the company addresses the items needed to bring Olinvo to market.

TODAY'S FREE FLY STORIES

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:31
08/22/19
08/22
07:31
08/22/19
07:31
Earnings
Dick's Sporting raises FY19 EPS view to $3.30-$3.45 from $3.20-$3.40 

FY19 consensus $3.31.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

PSTG

Pure Storage

$13.87

0.2 (1.46%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Oct

  • 12

    Dec

  • 16

    Dec

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Earnings
Dick's Sporting reports Q2 EPS $1.26, consensus $1.21 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

NBL

Noble Energy

$22.22

-0.02 (-0.09%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Upgrade
Noble Energy rating change  »

Noble Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 02

    Oct

TSLA

Tesla

$220.89

-4.81 (-2.13%)

, TGT

Target

$103.11

17.54 (20.50%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

TSLA

Tesla

$220.89

-4.81 (-2.13%)

TGT

Target

$103.11

17.54 (20.50%)

BCS

Barclays

$6.71

0.025 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 19

    Sep

  • 23

    Sep

  • 25

    Sep

  • 10

    Oct

  • 27

    Oct

FUN

Cedar Fair

$55.07

0.88 (1.62%)

07:28
08/22/19
08/22
07:28
08/22/19
07:28
Upgrade
Cedar Fair rating change  »

Cedar Fair upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

TIF

Tiffany

$84.51

2.27 (2.76%)

07:26
08/22/19
08/22
07:26
08/22/19
07:26
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

NVO

Novo Nordisk

$51.82

0.54 (1.05%)

07:26
08/22/19
08/22
07:26
08/22/19
07:26
Hot Stocks
Novo Nordisk says EC grants extension of indication for Fiasp »

Novo Nordisk announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 25

    Sep

AZN

AstraZeneca

$45.42

0.8 (1.79%)

07:24
08/22/19
08/22
07:24
08/22/19
07:24
Hot Stocks
AstraZeneca agrees to buy FDA Priority Review Voucher from Sobi for $95M »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 16

    Sep

  • 25

    Sep

  • 02

    Oct

AAPL

Apple

$212.69

2.34 (1.11%)

07:23
08/22/19
08/22
07:23
08/22/19
07:23
Periodicals
Apple plans to launch Pro iPhones with 3-sensor camera systems, Bloomberg says »

Apple is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$45.42

0.8 (1.79%)

, FGEN

FibroGen

$44.90

0.36 (0.81%)

07:23
08/22/19
08/22
07:23
08/22/19
07:23
Hot Stocks
AstraZeneca says Roxadustat approved in China for new anemia indication »

AstraZeneca (AZN)…

AZN

AstraZeneca

$45.42

0.8 (1.79%)

FGEN

FibroGen

$44.90

0.36 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 16

    Sep

  • 25

    Sep

  • 02

    Oct

DK

Delek US

$33.35

0.555 (1.69%)

07:22
08/22/19
08/22
07:22
08/22/19
07:22
Downgrade
Delek US rating change  »

Delek US downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$30.14

4.165 (16.04%)

07:22
08/22/19
08/22
07:22
08/22/19
07:22
Recommendations
Pinduoduo analyst commentary  »

Pinduoduo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WORK

Slack Technologies

$30.81

0.315 (1.03%)

, MSFT

Microsoft

$138.77

1.52 (1.11%)

07:22
08/22/19
08/22
07:22
08/22/19
07:22
Initiation
Slack Technologies, Microsoft initiated  »

Slack Technologies…

WORK

Slack Technologies

$30.81

0.315 (1.03%)

MSFT

Microsoft

$138.77

1.52 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 04

    Sep

  • 10

    Sep

  • 27

    Oct

MSGN

MSG Networks

$14.78

-2.07 (-12.28%)

07:21
08/22/19
08/22
07:21
08/22/19
07:21
Recommendations
MSG Networks analyst commentary  »

MSG Networks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$103.11

17.54 (20.50%)

07:19
08/22/19
08/22
07:19
08/22/19
07:19
Recommendations
Target analyst commentary  »

Target price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

MSG

Madison Square Garden

$260.99

-6.38 (-2.39%)

07:19
08/22/19
08/22
07:19
08/22/19
07:19
Initiation
Madison Square Garden initiated  »

Madison Square Garden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$108.00

9.96 (10.16%)

07:16
08/22/19
08/22
07:16
08/22/19
07:16
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 20

    Nov

COO

Cooper Companies

$332.66

0.39 (0.12%)

, ESLOY

EssilorLuxottica

$0.00

(0.00%)

07:12
08/22/19
08/22
07:12
08/22/19
07:12
Recommendations
Cooper Companies, EssilorLuxottica analyst commentary  »

Cooper Companies price…

COO

Cooper Companies

$332.66

0.39 (0.12%)

ESLOY

EssilorLuxottica

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 04

    Sep

CERN

Cerner

$71.77

0.44 (0.62%)

07:12
08/22/19
08/22
07:12
08/22/19
07:12
Upgrade
Cerner rating change  »

Cerner upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

TGT

Target

$103.11

17.54 (20.50%)

07:12
08/22/19
08/22
07:12
08/22/19
07:12
Recommendations
Target analyst commentary  »

Target price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

SLM

Sallie Mae

$8.29

0.07 (0.85%)

07:11
08/22/19
08/22
07:11
08/22/19
07:11
Recommendations
Sallie Mae analyst commentary  »

Sallie Mae added to US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ORBC

Orbcomm

$4.84

-0.055 (-1.12%)

07:10
08/22/19
08/22
07:10
08/22/19
07:10
Upgrade
Orbcomm rating change  »

Orbcomm upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLSD

Clearside Biomedical

$1.27

0.09 (7.66%)

07:10
08/22/19
08/22
07:10
08/22/19
07:10
Hot Stocks
Clearside Biomedical plans to resubmit XIPERE NDA in 1Q20 »

Clearside Biomedical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

RCKT

Rocket Pharmaceuticals

$11.44

0.115 (1.02%)

07:09
08/22/19
08/22
07:09
08/22/19
07:09
Hot Stocks
Rocket Pharmaceuticals announces clearance to commence Phase 2 FANCOLEN-II trial »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.